StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

Estra-1,3,5(10)-trien-3,17β-diol-17-(cyclopentanpropionat)

Estradiol Cypionate

HCID 9403
Neue Reaktion
Drucken
GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
313-06-4
Standard-SMILES
C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2OC(=O)CCC1CCCC1
InChIKey
UOACKFBJUYNSLK-XRKIENNPSA-N
Summenformel
C26H36O3
Durchschnittliche Molmasse
396,6 g/mol
Monoisotopische Masse
396,26644501

Überblick

Estradiol 17beta-cyclopentylpropionate is a steroid ester.

Namen und Bezeichner

Bevorzugter Name
Estradiol Cypionate
IUPAC
[(8R,9S,13S,14S,17S)-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] 3-cyclopentylpropanoate
Lokaler Name
Estra-1,3,5(10)-trien-3,17β-diol-17-(cyclopentanpropionat)
Englischer Name
Estradiol Cypionate
Summenformel
C26H36O3
Molmasse
396.57

Namen und Synonyme

estradiol cypionate313-06-4Depo-EstradiolEstradiol cipionateEstradiol, 17-cyclopentanepropionateDTXSID402299917beta-Estradiol 17-cyclopentylpropionateNSC-33547E1DV054LONSC3354Estradiol cypionate (USP)Estradiol cypionate [USP]
Weitere Namen anzeigen
EstrofemEstradial Cypionateβ-Estradiol 17-cypionateEstradiol cyclopentylpropionate(17b)-estra-1,3,5(10)-triene-3,17-diol17-cyclopentanepropanoate3-cyclopentylpropanoic acid [(13S)-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] esterDepogenEstrapo
DTXCID302999Estra-1,3,5(10)-triene-3,17-diol (17beta)-, 17-cyclopentanepropanoateESTRADIOL 17beta-CYCLOPENTANEPROPANOATEEstra-1,3,5(10)-triene-3,17-diol, (17beta)-, 17-cyclopentanepropanoateRefChem:55136206-237-8DepofeminDepoestradiol

Eigenschaften

Berechnete Struktureigenschaften

XLogP
7,1
Polarare Oberfläche (TPSA)
46,5 Ų
H-Brücken-Donoren
1
H-Brücken-Akzeptoren
3
Frei drehbare Bindungen
5
Schwere Atome
29
Formalladung
0
Komplexität
597

Experimentelle und physikochemische Eigenschaften

DrugsPharmaceuticals -> Listed in ZINC15
Human Drugs · 4 Einträge

Breast Feeding; Lactation; Milk, Human; Estrogens; Hormones

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Pharmaceuticals

Endocrine DisruptorsPotential endocrine disrupting compound
Collision Cross Section220.4 Ų [M-H]- [CCS Type: DT; Buffer gas: N2; Ionization: ESI-; Dataset: TOXCAST; Source Identifier: DTXSID4022999]

Physikochemische Eigenschaften

Schmelzpunkt
151 · 151-152°
Siedepunkt
460.24 °C · 460.24°C (rough estimate)
Dichte
1.0828 · 1.0828 (rough estimate)
Brechungsindex
1.47 · 1.4700 (estimate)
storage temp.
Refrigerator
Löslichkeit

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 4 Einträge

Danger

H302 (95.1%): Harmful if swallowed [Warning Acute toxicity, oral]

P203, P261, P264, P270, P271, P280, P301+P317, P302+P352, P304+P340, P317, P318, P321, P330, P362+P364, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 41 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Gefahrenhinweise

Regulatory Information · 1 Eintrag

Estra-1,3,5(10)-triene-3,17-diol (17.beta.)-, 17-cyclopentanepropanoate: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.

Other Safety InformationIMAP assessments - Estra-1,3,5(10)-triene-3,17-diol, 17-cyclopentanepropanoate, (17.beta.)-: Environment tier I assessment
Hazard Classes and CategoriesAcute Tox. 4 (95.1%)

Toxikologische Informationen

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation

Sicherheitsdaten

wgk
3
tsca
TSCA listed
hs_code
29372390
RTECS-Nr.

Chemie und Industrie

Pharmakologische Informationen

Protein BindingEstrogens circulate in the blood largely bound to sex hormone binding globulin (SHBG) and albumin.
Pharmacodynamics · 1 Eintrag

Estrogen mediates its effects across the body through potent agonism of the Estrogen Receptor (ER), which is located in various tissues including in the breasts, uterus, ovaries, skin, prostate, bone, fat, and brain. Estradiol binds to both subtypes of the Estrogen Receptor: Estrogen Receptor Alpha (ERα) and Estrogen Receptor Beta (ERβ). Estradiol also acts as a potent agonist of G Protein-coupled Estrogen Receptor (GPER), which has recently been recognized as a major mediator of estradiol's rapid cellular effects.

Mechanism of Action · 1 Eintrag

Estradiol enters target cells freely (e.g., female organs, breasts, hypothalamus, pituitary) and interacts with a target cell receptor. When the estrogen receptor has bound its ligand it can enter the nucleus of the target cell, and regulate gene transcription which leads to formation of messenger RNA. The mRNA interacts with ribosomes to produce specific proteins that express the effect of estradiol upon the target cell. Estrogens increase the hepatic synthesis of sex hormone binding globulin (SHBG), thyroid-binding globulin (TBG), and other serum proteins and suppress follicle-stimulating hormone (FSH) from the anterior pituitary. Increases in the down-stream effects of ER binding reverses some of the symptoms of menopause and of hypoestrogenism, which are primarily caused by a loss of estrogenic activity.

Metabolism/Metabolites · 1 Eintrag

Exogenous estrogens are metabolized in the same manner as endogenous estrogens. Circulating estrogens exist in a dynamic equilibrium of metabolic interconversions. These transformations take place mainly in the liver. Estradiol is converted reversibly to estrone, and both can be converted to estriol, which is the major urinary metabolite. Estrogens also undergo enterohepatic recirculation via sulfate and glucuronide conjugation in the liver, biliary secretion of conjugates into the intestine, and hydrolysis in the gut followed by reabsorption. In postmenopausal women, a significant proportion of the circulating estrogens exist as sulfate conjugates, especially estrone sulfate, which serves as a circulating reservoir for the formation of more active estrogens.

Zugehörige Reaktionen

1
Reaktionsaufzeichnung erstellen
Reaktionsgleichung von HRID 868693
HRID 868693als Edukt

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung

Datenbank-Bezeichner

CAS
313-06-4
PubChem CID
9403
DTXSID
DTXSID4022999
ChEMBL
CHEMBL1200973
ChEBI
CHEBI:34745
UNII
7E1DV054LO
EC Number
206-237-8
Nikkaji
J5.661H
Chloroform (Slightly), Methanol (Slightly)
pka
10.25 · 10.25±0.60(Predicted)
Aggregatzustand
Solid
Farbe
White to Off-White
Biologische Quelle
synthetic (organic)
InChIKey
UOACKFBJUYNSLK-JCRQLOERNA-N
SMILES
C[C@]12CC[C@]3([H])C4C=CC(O)=CC=4CC[C@@]3([H])[C@]1([H])CC[C@@H]2OC(=O)CCC1CCCC1 |&1:1,4,15,17,21,r|
CAS Datenbank
313 · 313-06-4(CAS DataBase Reference)
NIST chemische Informationen
Estradiol cypionate(313-06-4)
EPA chemische Informationen
-1 · Estra-1,3,5(10)-triene-3,17-diol (17.beta.)-, 17-cyclopentanepropanoate (313-06-4)
KG4600000
risk_code
45-46-61-20/21/22-36/37/38
hazard_code
T,Xi
safety_code
53-22-36/37/39-45-26
Speicherklasse
6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
Hazard Classifications
Acute Tox. 4 DermalAcute Tox. 4 InhalationAcute Tox. 4 OralCarc. 1BRepr. 1B
FDA Pharmacological Classification · 2 Einträge

ESTRADIOL CYPIONATE

Estradiol Congeners [CS]; Estrogen [EPC]; Estrogen Receptor Agonists [MoA]

MeSH Pharmacological Classification · 2 Einträge

Chemical substances or agents with contraceptive activity in females. Use for female contraceptive agents in general or for which there is no specific heading.

Contraceptive agents that act on the ENDOCRINE SYSTEM.

Absorption, Distribution and Excretion · 3 Einträge

When conjugated with aryl and alkyl groups for parenteral administration, the rate of absorption of oily preparations is slowed with a prolonged duration of action, such that a single intramuscular injection of estradiol valerate or estradiol cypionate is absorbed over several weeks.

Estradiol, estrone and estriol are excreted in the urine along with glucuronide and sulfate conjugates.

The distribution of exogenous estrogens is similar to that of endogenous estrogens. Estrogens are widely distributed in the body and are generally found in higher concentrations in the sex hormone target organs.

Verwendung und Herstellung

Use ClassificationPharmaceuticals
General Manufacturing InformationEstra-1,3,5(10)-triene-3,17-diol (17.beta.)-, 17-cyclopentanepropanoate: INACTIVE
Anwendungen · 1 Eintrag

VerwendenEstradiol Cypionate is the cypionate salt form of estradiol, the most potent, naturally produced estrogen. Estradiol Cypionate is present in injectable contraceptive formulations. Used in hormone replacement therapy with potential for improving cognition in post-menopausal women.

Vor- und nachgelagerte Produkte

Vorgelagerte Rohstoffe

Kaliumcarbonat3-CyclopentylpropionylchloridEstra-1,3,5(10)-trien-3,17β-diolbis(cyclopentanpropionat)Estradiol

Ergänzende Hinweise

DefinitionChEBI: Estradiol 17beta-cyclopentylpropionate is a steroid ester. It inhibits ET-1 synthesis via estrogen receptor.